LONDON (AP) — The pharmaceutical developer Novavax says it has asked the European Medicines Agency to extend the authorization of its coronavirus vaccine to children aged 12 to 17 amid a surge of disease across the continent.
In a statement on Thursday, Novavax said its request is based on data from ...
from The Washington Times stories: Health https://ift.tt/l1P7o2m